X0306 4 2017-05-17 0 0001512762 Coherus BioSciences, Inc. CHRS 0001459154 Wahlstrom Mats C/O COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 1 0 0 0 Common Stock, $0.0001 par value 2017-02-22 4 J 0 200000 0.00 D 378528 I See Footnote Common Stock, $0.0001 par value 2017-02-22 4 J 0 109957 0.00 A 109957 I See Footnote Common Stock, $0.0001 par value 2017-05-09 4 J 0 200000 0.00 D 178528 I See Footnote Common Stock, $0.0001 par value 2017-05-09 4 J 0 109957 0.00 A 219914 I See Footnote Stock Option (Right to Buy) 23.80 2017-05-17 4 A 0 20000 0.00 A 2027-05-17 Common Stock 20000 20000 D KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. The shares are held by KMG Capital Partners, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein. The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein. KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017. Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC. The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean-Frederic Viret, as Attorney-in-Fact for Mats Wahlstrom 2017-05-19